Burcu Biltekin

6PUBLICATIONS
18CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Carbon capture engineering (excl. sequestration)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 15, 2026
Modulation of Drug Resistance and Apoptotic Pathways Underlies the Enhanced Antitumor Effect of Ellagic Acid-Irinotecan Combination in Glioma.

|May 27, 2026
Screening the Combination of Gemcitabine, Clomipramine, and Resveratrol in HL-60 Leukemia Cells.

|Apr 14, 2026
Resveratrol as a Modulator of Adriamycin-, Taxol-, and Cisplatin-Induced Cytotoxicity in MCF-7 Breast Cancer Cells.

Burcu Biltekin, Hafize Uzun, Ayhan Bilir

|Mar 28, 2026
Combined Antineoplastic Effects of Metformin, Boric Acid and Resveratrol in SKOV3 Ovarian Cancer Cells.

Burcu Biltekin, Mete Hakan Karalok, Seyma Dumur

|Aug 10, 2022
Antitumor activity of irinotecan with ellagic acid in C6 glioma cells.

Abdurrahman Cetin, Burcu Biltekin, Huseyin Ozevren

|Mar 17, 2021
Cordycepin prevents the esophageal stricture formation in the alkali-burn rat model by exerting anti-inflammatory and antifibrotic effects.

Gulcin Ercan, Yuksel Altinel, Onur Olgac Karagulle

Pageof 1

Frequent Collaborators

2 joint publications

Ayhan Bilir

2 joint publications

Hafize Uzun

2 joint publications

Abdurrahman Cetin

1 joint publications

Gulcin Ercan